Germany-based Evotec SE (NASDAQ:EVO) is trading on Monday after a report that suggests the company is a takeover target. The ...

Shares in Evotec jumped as much as 13.3% on Monday after regulatory filings showed private equity firm Triton had built an over 9% stake in the German drug development company.

Triton Partners, is considering a takeover bid Evotec , Eyk Henning of Bloomberg reported earlier, citing people familiar with the matter. Triton is among several investment firms ...

Evotec shares soared after the company said private equity group Triton had acquired about 10% of its stock. Luxembourg-based private equity firm Triton acquired a total of 17,730,913 ordinary shares ...

Evotec’s struggles have put it in the crosshairs of private equity groups. After seeing the company’s share price fall around ...

(Bloomberg) -- Triton Partners is considering a takeover bid for Germany’s Evotec SE, according to people familiar with the matter, after the private equity firm emerged as one of the drug developer’s ...

Evotec confirmed to Reuters that Triton now holds a 9.99% stake in the company, making it its biggest shareholder, but said this had no impact on its day-to-day operations. Triton raised its stake to ...

Updates shares, adds further details. Evotec SE (NASDAQ:EVO) ADRs surged 18% after a report that Triton Partners is considering a takeover offer for the German drug developer. Triton is among one of ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

European shares opened higher on Monday with most sectors rising, kicking off a week packed with global economic data ...

Evotec surged on Monday as it emerged that private equity firm Triton Partners is considering a takeover bid for the German drug development company after taking a near-10% stake.

Europe’s shares rose on Monday, with defence stocks feeling the benefit amid hopes for higher spending in Europe under Donald ...